Home > Financial Ratios > TTK HEALTHCARE

TTK HEALTHCARE
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for TTK HEALTHCARE
Please provide your vote to see the results

TTK HEALTHCARE Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 25.42108.7630.47-21.08-35.31

What is the latest Core EBITDA Growth ratio of TTK HEALTHCARE ?

The latest Core EBITDA Growth ratio of TTK HEALTHCARE is 25.42 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar202425.42
Mar2023108.76
Mar202230.47
Mar2021-21.08
Mar2020-35.31

How is Core EBITDA Growth of TTK HEALTHCARE Trending?

Years Core EBITDA Growth % Change
Mar2024 25.42
-76.63
Mar2023 108.76
256.94
Mar2022 30.47
Positive
Mar2021 -21.08
Negative
Mar2020 -35.31 -

Other Financial Ratios of TTK HEALTHCARE


Compare Core EBITDA Growth ratio of peers of TTK HEALTHCARE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TTK HEALTHCARE ₹1,757.5 Cr -2.8% -5.3% -13.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹415,697.0 Cr -2% -0.8% 16.6% Stock Analytics
DIVIS LABORATORIES ₹157,449.0 Cr -2.7% 3.5% 66.7% Stock Analytics
CIPLA ₹117,778.0 Cr 0.7% 1.4% 3.7% Stock Analytics
DR REDDYS LABORATORIES ₹101,871.0 Cr 0.1% -8.5% 0.7% Stock Analytics
ZYDUS LIFESCIENCES ₹97,046.2 Cr -0.9% -1% 24% Stock Analytics


TTK HEALTHCARE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TTK HEALTHCARE

-2.8%

-5.3%

-13.8%

SENSEX

0.2%

-0.1%

7.2%


You may also like the below Video Courses